Catch The Wave of June CASE

The latest issue of CASE is now available with intriguing reports, including “The Complex Hemodynamic Interplay between Mitral Arcade, Midventricular Obstruction, and Prosthetic Aortic Valve” by Taverna et al. CASE Editor-in-Chief Vincent Sorrell, MD, FASE, remarked, “One of the great values of CASE is the ability to use high-quality echo images matched to tomographic cardiovascular imaging to educate readers about rare diseases they are unlikely to see in their individual clinical practice. This month’s issue fulfills that goal with the report from Taverna that showcases mitral arcade; there are not very many published reports in adults owing to both its rarity and possible under-diagnosis. During the editorial review process, these authors worked closely with section editors who are experts in congenital heart disease to provide readers with very precise descriptions, concluding that this patient likely met criteria for a partial Shone’s complex. They also use very detailed volume-rendered 3D-CT images to demonstrate how the pathoanatomy of this particular mitral arcade is atypical and consists of a double-bridge connecting the anterior and posterior leaflets to the papillary muscles. In summary, the authors rightly conclude that a comprehensive multimodal cardiac imaging approach (CT for anatomy; echo Doppler for physiology) is essential!”

Following that Multimodality Imaging report, authors in Infections in the Heart present a report titled, “Vegetations Lurking in the Dark and the Role of Neoendothelialization,” reviewing the published literature on this potential complication and discussing the possible risk-assessment role of cardiac CT by monitoring neoendothelization in these devices. Over in the Hemodynamic Corner of CASE, there are two reports: one on the importance of spectral Doppler in detecting mitral regurgitation in patients with acoustic shadowing from prosthetic valves, and one that describes the unique mitral and tricuspid spectral Doppler inflow patterns in a patient with non-sinus rhythm. With high-quality 2D and 3D echo images, a case in Rare But Deadly Findings offers a learning lesson to readers about a left atrial dissection after complications of mitral valve surgery. To round out this issue, there is a letter to the editor discussing a previous CASE on a novel transcatheter approach to treat primum atrial septal defects with a response from that article’s authors.

As with all CASE issues, these reports demonstrate the value of quality imaging over quantity. Be sure to read Dr. Sorrell’s editorial as he explores how to maintain this principle in a healthcare environment that increasingly rewards growth and productivity.

Looking for a journal to submit your case report to? We want to hear from you! Email us with questions or submit your report today.

Arthur Weyman ASE’s 8th President Passed Away

It is with great sadness that we write to inform our members that Arthur (Ned) E. Weyman, MD, FASE, passed away this morning, June 17, 2024. Dr. Weyman was ASE’s first secretary of the Board of Directors and subsequently served as the 8th President of ASE serving from January 1991 through June 1993. He received a 2001 American College of Cardiology Gifted Teacher Award and a University of Medicine and Dentistry of New Jersey 2004 Distinguished Alumnus Award. ASE’s Arthur E. Weyman Young Investigator’s Award (YIA) was created in 2007 in honor of Dr. Weyman’s unwavering commitment to research in cardiovascular ultrasound. He received ASE’s Meritorious Service Award in 2012 recognizing his contributions to the field and ASE. Dr. Weyman was also a driving force behind the creation of the National Board of Echocardiography. He served as their first president and remained on their board in an emeritus status. In his honor, the NBE has supported the ASE’s YIA award since 2007.

He completed his medical degree at New Jersey College of Medicine in 1966 and proceeded to his first residency at St. Vincent’s Hospital in New York. He then put his residency on hold while he served in the U.S. Navy as a Marine squadron and air group flight surgeon from 1968-1971. Upon returning, he completed a second year and chief residency at St. Vincent’s, followed by a three-year cardiology fellowship at Indiana University, where he was a fellow in training under ASE’s Founder Dr. Harvey Feigenbaum. In 1980, Dr. Weyman moved to Massachusetts General Hospital and Harvard Medical School in Boston, MA, where he spent the rest of his illustrious career before retiring in 2022. Named Mass General’s chief of cardiology in 1994, his development of innovative methods, research models and exemplary mentoring led the way for echocardiography to become the go-to assessment tool for heart and vascular imaging. He built the echocardiography laboratory into a powerhouse for research, education, and clinical productivity. Known as “the mentor of mentors,” Dr. Weyman and the Mass General echo lab became the place where countless physicians and sonographers competed for fellowships to train in his lab and learn to be great echocardiographers and leaders including seven ASE Presidents.

As one of the founding leaders in echocardiography, he advocated tirelessly for international recognition of the pivotal role the noninvasive assessment tool plays in saving lives by quickly detecting cardiac issues in patients from infants to adults. His presence at the helm of ASE and NBE changed the field forever. He will be missed and we are forever grateful for his service.

A devoted family man, Weyman leaves behind his wife, Jean, their four children and grandchildren.

Listen to a 2009 interview with Dr. Weyman on ASE’s YouTube channel.

A funeral Mass for Dr. Weyman will be held in St. Paul Church, 502 Washington St., Wellesley on Saturday, June 22, at 10AM. Relatives and friends kindly invited. The Mass will also be live streamed at Interment in Woodlawn Cemetery, Wellesley.

ASE 2024 Research Spotlight 1

Contact: Angie Porter

Two Research Studies at ASE 2024 Examine Environmental Factors and Heart Health

(DURHAM, NC, June 14, 2024)—A number of factors can determine a person’s heart health—genetics, physical activity, diet, and even the environment. Two international research studies that will be presented during the American Society of Echocardiography’s (ASE) 35th Annual Scientific Sessions, June 14-16, 2024, in Portland, Oregon, examined the effects the latter on the heart.

The first study, titled “Maternal Exposure to Ambient Ozone and Fetal Conotruncal Congenital Heart Defects in China: A Large Multicenter Cohort Study,” delves into the effects of ozone (O3) pollution on fetal heart development. From January 2013 to December 2021, the study examined more than 24,000 pregnant women at Beijing Anzhen Hospital, Capital Medical University in China to investigate the association between maternal exposure to O3 and conotruncal heart defects (CTDs), which are congenital heart malformations that affect the heart’s outflow tracts and great arteries.

Fetal echocardiography was used to evaluate fetuses with CTDs, and the research findings revealed that maternal exposure to ambient O3 pollution during critical periods, especially during the periconception period, may increase the risk of CTDs in fetuses.

“To prevent this impact, pregnant women should adopt healthy lifestyles and avoid exposure to O3 pollution during peak hours, which can occur in traffic congested or industrial areas,” says the study’s lead author, Yihua He, an expert in fetal congenital heart disease and the Director of the Echocardiography Medical Center and Maternal-fetal Medicine Center in Fetal Heart Disease at Beijing Anzhen Hospital, Capital Medical University. “Additionally, governments and the public should implement measures to decrease O3 pollution, such as reducing emissions from industrial and transportation sources, promoting clean energy, and implementing air quality standards.”

Dr. He emphasized the need for further research to understand the impact of other environmental factors on fetal heart development and to develop appropriate preventive measures.

The second study, titled “Echocardiographic Assessment of Pulmonary and Right Chamber Parameters in Healthy Individuals Who Live More Than 8200 Feet Above the Sea Level: A Colombian Experience,” focused on long-term cardiopulmonary adjustments in individuals residing at high altitudes, specifically those living more than 8,200 feet above sea level (FASL).

The study, conducted in the Andean Mountains in Colombia, where over 35 million people live at such altitudes, examined the prevalence of high-altitude pulmonary hypertension and its implications on the right ventricle and clinical outcomes. Contrary to what was expected, the findings indicated that individuals living above 8200 FASL do not exhibit higher estimated systolic pulmonary artery pressure (sPAP) or significant differences in right ventricle dimensions and function.

However, findings did discover a significant difference between the study’s two Colombian cohorts from Bogota (8,612 FASL) and Aquitania (9,941 FASL). There was a surprisingly higher prevalence of Stage 2 hypertension and an increase in relative wall myocardium thickness in the Aquitania cohort. It was determined there is a need for further investigation into the long-term adaptive mechanisms in adults residing at high altitudes, as it may lead to adverse cardiovascular outcomes.

“The effects of pulmonary and arterial hypertension include capillary remodeling and permeability changes that result in pressure load on the right or left ventricle respectively. If uncontrolled, changes can lead to ventricular failure with a reduced exercise capacity and premature death. Therefore, if undiagnosed, high-altitude dwellers could be at risk of developing clinically relevant events,” says the study’s lead author Astrid Lorena Rodriguez, an internal medicine resident at Fundacion Santa Fe, Bogota in Colombia. “We expect our results to encourage global leaders and colleagues to further research long-term cardiopulmonary adjustments to better understand clinical outcomes in this population.”

Both research studies will be presented at the Oregon Convention Center during ASE 2024, which features more than 450 abstract presentations showcasing cutting-edge research on the latest advances in cardiovascular ultrasound and cases illustrating breakthroughs in patient care. Learn more about ASE 2024 and download the conference’s final event program at

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information visit ASE’s website or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.


Calling All Future Leaders: ASE Leadership Academy Cohort 4 Application is NOW OPEN

Are you interested in becoming a future ASE leader or do you know someone who may be interested? Now is the time to apply for a position in the 2024-2026 class of the ASE Leadership Academy.
ASE is committed to the professional growth of its members, and this program provides a unique opportunity for ASE members to increase their knowledge and develop skills that will help them be successful leaders throughout their careers. During this 19-month program, participants will be matched with a senior adviser and receive access to high-quality, online tutorials on leadership topics valued at over $7,500.
Applications and recommendation letters will be accepted through August 1, 2024. Questions? Email

Jumpin’ for June JASE

The June issue of JASE includes, “Obstruction in Hypertrophic Cardiomyopathy: Many Faces.” Author Jeffrey B. Geske, MD, FASE, remarks, “Echocardiographic assessment of obstructive hypertrophic cardiomyopathy can be challenging due to vast phenotypic heterogeneity, complex hemodynamics, and variable findings dependent on loading conditions. However, accurate diagnostic assessment is needed for guidance of medical management, determination of septal reduction therapy candidacy, and intraprocedural assessment. In this JASE article, we present a visual Doppler atlas with many high-quality examples to guide interpretation and understanding of the many ways that obstruction can present in hypertrophic cardiomyopathy.”

In addition to the HCM report, readers can look forward to two other state-of-the-art reviews. Both center on the role of 3D echocardiography—in the perioperative assessment of the hemodynamic ventriculoarterial junction of the aortic root and in RV volume analysis in pediatric heart disease. This issue also hosts a variety of clinical investigations on topics ranging from left ventricular trabeculations in athletes to 3D echocardiography’s role in mitral regurgitation to congenital heart disease. Two editorial comments, five brief research communications, and two letters to the editor round out this issue.

In his final President’s Message, Dr. Eidem reflects on this past year as ASE President and the progress of his three key initiatives: ASE Matters, ASE Mentors, and ASE Educates. Be sure to check out June’s Author Spotlight to learn more from author Giuseppe Di Gioia, MD, on his recent paper, Left Ventricular Trabeculation: Arrhythmogenic and Clinical Significance in Elite Athletes.

Please see the June ASE Education Calendar for a listing of educational opportunities far and wide.

Access the Latest Free CME/MOC JASE Article in the ASE Learning Hub

As a benefit of ASE membership, you have access to over 25 free CME/MOC activities in the ASE Learning Hub (ALH)! The latest JASE CME article available in the ALH is titled, Pulmonary Vein Flow Morphology After Transcatheter Mitral Valve Edge-to-Edge Repair as Predictor of Survival. Members can access this article for free in the ALH and earn up to 1.5 AMA PRA Category 1 Credits™.

Official Countdown: 16 Days until ASE 2024 Download the Final Program for Event Details

The ASE 2024 Schedule Details is now available! Already registered? Use the Whova app to begin planning your schedule. Not yet registered? View the Schedule Details to see the many education and networking opportunities offered at ASE 2024, and register today (on site prices rise by $125)!
The 35th Annual Scientific Sessions— taking place in Portland, Oregon, June 14-16—will provide an environment for engaged learning, share groundbreaking research, and explore the latest advancements in cardiovascular ultrasound. Both in-person and virtual registration options are available.
Highlights this year include:
  • Joint sessions with 17 partnering multimodality organizations.
  • Four featured special lectures.
  • Sonographer Career Day on Saturday where sonographer students are encouraged to attend and learn for the day.
  • Six Science & Technology Theater presentations by industry in the Echo Expo.
  • Eleven Poster Sessions and three Rapid Fire Abstract Presentations.
  • Exhibit Floor with over 50 booths, Bark Park sponsored by Siemens Healthineers, Coffee Carts, Charging Lounges, and Research Posters.
  • And more!

Now Available: 2024 Coding Connection Newsletter

ASE is committed to providing our members with the tools and resources they need to ensure coding accuracy and compliancy, and to maximize appropriate revenue. Log in to the ASE Member Portal and access the 2024 Coding Connection document under the “Advocacy” tab.

This free resource provides answers to echocardiography specific billing and assists you in coding accurately for the services you provide, especially in today’s environment of declining reimbursement and increased scrutiny. This newsletter includes information on recent coding updates for echocardiography services, evaluation and management services, Medicare split/shared visit changes, and ASE’s top 10 coding questions and answers.

ASE provides member-only access to coding information and a coding expert who is available to answer individual coding questions free of charge.

Join an ASE Council or Specialty Interest Group

ASE is an organization that is open to all echo enthusiasts, and a diverse and active membership not only makes ASE stronger, but also the field of cardiovascular ultrasound. As a free member benefit, members can choose to join one (or more) of ASE’s six Councils or four Specialty Interest Groups (SIGs).

ASE’s Councils provide members with an opportunity to be involved with one or more subspecialty group to enhance their careers and knowledge, and Council membership is free. The 2024 Scientific Sessions in Portland, Oregon, offers multiple opportunities to engage with Council members, including Council Business Meetings (see Whova App for schedule).

  • Cardiovascular Sonography
  • Circulation & Vascular Ultrasound
  • Critical Care Echocardiography
  • Interventional Echocardiography
  • Pediatric and Congenital Heart Disease
  • Perioperative Echocardiography

SIGs support members who have a common interest in specialized areas with growth potential in cardiovascular ultrasound. There are currently four SIGs that members can join for free. Meet members of SIG leadership at a Networking Event on Friday, June 14 during the President’s Welcome Reception.

  • Cardio-Oncology
  • Emerging Echo Enthusiasts
  • Neonatal Hemodynamics TnECHO
  • Veterinary

Join an ASE Council or SIG, by logging in to your ASE Member Portal. Contact Suzanne Morris at with questions about Councils, and email with questions about joining a SIG.

Registration is Open for Advanced Echo 2024

Did you miss Echo Hawaii or State-of-the-Art Echocardiography (SOTA) earlier this year? Or maybe you are looking for unlimited on-demand access to the latest education on established and emerging cardiovascular ultrasound technologies? Register for ASE’s Advanced Echo 2024 online course and access 28 presentations compiled from the 2024 Echo Hawaii and SOTA courses. Expert faculty discuss the latest technologies with a particular focus on how they can be effectively applied in a clinical setting.

Registration includes access to course materials until April 16, 2025; up to 13.75 AMA PRA Category 1 Credits™, and ASE members receive reduced registration fees as a benefit of membership.